Siemens Sets a New Standard for Breast Ultrasound

SiemensSiemens Healthcare recently introduced the Acuson S2000 Automated Breast Volume Scanner (ABVS), the first multi-use ultrasound breast system that automatically acquires volume images of the breast. Thanks to the user-independent, standardized image acquisition, the system is ideally suited for early detection and diagnosis of breast cancer with ultrasound - especially for women with dense breast tissue.

According to the New England Journal of Medicine(1), dense breast tissue increases the risk of breast cancer for a woman up to five-fold. While mammogr phy remains the method of choice in breast cancer screening, a study published by the RSNA (Radiological Society of North America) in 2002(2) showed that the detection rate for non-palpable, invasive breast cancer increased by 42 percent when mammography was followed by an ultrasound examination.

"I am convinced that automatic ultrasound volume imaging with the Acuson S2000 ABVS can make a significant contribution in diagnostic confidence for women with dense breast tissue or inconclusive mammography findings," said Klaus Hambüchen, CEO, Ultrasound at Siemens Healthcare. Examinations performed with the Acuson S2000 ABVS technique generally take less than 15 minutes. "Time well spent if you consider the extended diagnostic capabilities of ultrasound in dense breasts."

Coronal anatomical view
The system quickly and comfortably acquires and surveys full-field sonographic volume images that provide a more comprehensive overview of the breast. Included is the intuitive, anatomical coronal plane of the breast (from the nipple to the breast wall), which is not available with conventional ultrasound imaging. This view provides a more understandable representation of the global anatomy and architecture of the breast.

The system's automatic image acquisition significantly improves the workflow of a breast ultrasound examination. While hand held examinations usually take up to 30 minutes, with the Acuson S2000 ABVS, the exam can be performed in less than 15 minutes. Semi-automated reporting and comprehensive BI-RADS® ultrasound reporting capabilities further enhance the clinical workflow. This Breast Imaging Reporting and Data System (BI-RADS) is a classification of the American College of Radiology (ACR) for reporting mammography screenings.

To further optimize high-volume patient care, the system also supports innovative breast imaging applications, such as Fatty Tissue and eSie Touch elasticity imaging. All of these applications help increase diagnostic confidence, while at the same time reducing examination and waiting time for the patient. The new system is an all-round system for ultrasound breast care, from early detection, to diagnosis to aftercare.

Related news articles:

About Siemens Healthcare
The Siemens Healthcare Sector is one of the largest suppliers of healthcare technology in the world. The company is a medical solution provider with core competences and innovative strengths in diagnostic and therapeutic technologies as well as knowledge processing, including information technology and system integration. With its acquisitions in laboratory diagnostics, Siemens Healthcare is the first integrated healthcare company that combines imaging and lab diagnostics, therapy solutions and medical information technology and also supplements these with consultation and services. Siemens Healthcare offers solutions for the entire supply chain under one roof - from prevention and early detection to diagnosis and on to treatment and aftercare. In addition, Siemens Healthcare is the global market leader for innovative hearing instruments. The company employs some 49,000 employees worldwide and is present in more than 130 countries. During fiscal 2008 (ending on September 30), Siemens Healthcare achieved sales of 11.17 billion euros and incoming orders totaling 11.78 billion euros. The Sector profit from operations amounted to 1.23 billion euros. For more information, go to: http://www.siemens.com/healthcare.

1. N Engl J Med 356;3. Boyd N.F. et Al., Mammographic Density and the Risk and Detection of Breast Cancer
2. Radiology 2002;225:165-175. Kolb T.M. et Al., Comparison of the Performance of Screening Mammography, Physical Examination, and Breast US and Evaluation of Factors that Influence Them: An Analysis of 27,825 Patient Evaluations

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...